Axiom Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Axiom Investment Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,000	Closed	-$301K	–	147
2021 Q4	$301K	Hold	2,000	–	–	0.29%	87
2021 Q3	$239K	Buy	+2,000	New	+$220K	0.24%	96
2020 Q4	–	Sell	-2,000	Closed	-$227K	–	150
2020 Q3	$227K	Buy	+2,000	New	+$210K	0.26%	97
2019 Q4	–	Sell	-9,350	Closed	-$552K	–	212
2019 Q3	$552K	Buy	+9,350	New	+$597K	0.42%	67

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Axiom Investment Management's TNDM Position: Q1 2022 in Review

Axiom Investment Management sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 2,000 shares — an estimated $301K sold.

Axiom Investment Management first reported a position in TNDM in Q3 2019 and held it in 4 quarters. The position peaked at $552K in Q3 2019. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

Axiom Investment Management reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
Axiom Investment Management sold 2,000 Tandem Diabetes Care shares in Q1 2022, an estimated $301K.
Axiom Investment Management first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 4 quarters.
Axiom Investment Management's Tandem Diabetes Care position peaked at $552K in Q3 2019.
379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Axiom Investment Management's 13F filing for Q1 2022, filed 13 May 2022.